Tendersinfo keep you informed about the latest events in the national and international Procurement Industry. Procurement News provides in-depth coverage of the procurement industry, including contract awards, contract additions, new contract wins, mergers and acquisitions. Tendersinfo through its tender news section provides an update on all domestic and global tendering opportunities, invitation to bid & trade leads.

Publish Date : 27-Jun-2015

Calmare Therapeutics Incorporated, (CTI), the pain mitigation company, has won a preliminary three-month extension of its General Services Administration (GSA) military contract (V797P-4300B), which was first awarded in 2010.

This contract extension is designed to continue the streamlined procurement process for U.S. military personnel along with their families and institutional customers globally who acquire Calmare® Pain Therapy Devices and its consumables.

Calmare Therapeutics President & CEO Conrad Mir, said, “This extension allows us to continue offering our Calmare® Pain Therapy device to U.S. military personnel and their families through the U.S. Veterans Administration to reduce and/or eliminate chronic neuropathic pain. With this extension, we can broaden our military contract footprint and gain contracts with embedded device sales components that will drive revenues – the Company’s prime directive in pursuing U.S. government sales.”

A huge number of U.S. military hospitals and clinics currently rely on CTI’s Calmare Pain Mitigation Therapy™, and CTI's pain mitigation solution offers comprehensive pain mitigation whereby pain may be eliminated for well over 3 to 4 months after the first full treatment regimen in those patients that are responders.

Go to previous page